Evidence mapPaperPMID 42222048Full record

ReviewMedicine international

Experimental atherosclerosis models in small animals (Review).

Mehmet Ertugrul Balkar, Hakan Parlakpinar

Abstract readReview
In one paragraph

Review in Medicine international. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Mehmet Ertugrul BalkarDepartment of Medical Pharmacology, Faculty of Medicine, Inonu University, 44280 Malatya, Türkiye.
Hakan ParlakpinarDepartment of Medical Pharmacology, Faculty of Medicine, Inonu University, 44280 Malatya, Türkiye.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Atherosclerosis refers to the accumulation of plaque in arteries and is the underlying cause of various serious vascular diseases, including coronary artery disease and ischemic stroke. These diseases pose a major threat to global health and are often fatal. Individuals predisposed to metabolic health conditions, such as familial hypercholesterolemia, hypertension or diabetes mellitus, often manifest atherosclerosis in the early stages. Because early-stage atherosclerosis is asymptomatic and typically progresses without obvious symptoms, its clinical detection remains challenging before the onset of notable vascular obstruction. The primary objective of the present review was to comprehensively address experimental atherosclerosis models that are commonly used in small animals, and to serve as a source of inspiration for the development of new pharmacological treatment protocols in the future. Numerous sources related to the importance of atherosclerosis, the disease process, pathophysiology, risk factors and experimental models developed in small animals were examined for the present review. Experimental atherosclerosis models are crucial for researchers to understand the disease process and to develop innovative treatments, and

Indexed as

animalatherosclerosisendotheliumexperimental modelshyperlipidemia

Identifiers

PMID42222048
PMCPMC13216755

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.